- Home
- CNMD vs TNDM Comparison
CNMD vs TNDM Comparison
Compare CNMD & TNDM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNMD
- TNDM
- Stock Information
- Founded
- CNMD 1970
- TNDM 2006
- Country
- CNMD United States
- TNDM United States
- Employees
- CNMD N/A
- TNDM N/A
- Industry
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- TNDM Medical/Dental Instruments
- Sector
- CNMD Health Care
- TNDM Health Care
- Exchange
- CNMD Nasdaq
- TNDM Nasdaq
- Market Cap
- CNMD 2.2B
- TNDM 1.9B
- IPO Year
- CNMD 1987
- TNDM 2013
- Fundamental
- Price
- CNMD $68.65
- TNDM $35.91
- Analyst Decision
- CNMD Buy
- TNDM Buy
- Analyst Count
- CNMD 6
- TNDM 16
- Target Price
- CNMD $82.83
- TNDM $52.06
- AVG Volume (30 Days)
- CNMD 428.8K
- TNDM 1.3M
- Earning Date
- CNMD 01-29-2025
- TNDM 02-19-2025
- Dividend Yield
- CNMD 1.17%
- TNDM N/A
- EPS Growth
- CNMD 127.53
- TNDM N/A
- EPS
- CNMD 4.22
- TNDM N/A
- Revenue
- CNMD $1,288,116,000.00
- TNDM $854,351,000.00
- Revenue This Year
- CNMD $6.69
- TNDM $23.98
- Revenue Next Year
- CNMD $7.53
- TNDM $10.89
- P/E Ratio
- CNMD $16.26
- TNDM N/A
- Revenue Growth
- CNMD 10.23
- TNDM 10.75
- 52 Week Low
- CNMD $61.05
- TNDM $21.85
- 52 Week High
- CNMD $114.80
- TNDM $53.69
- Technical
- Relative Strength Index (RSI)
- CNMD 39.61
- TNDM 60.83
- Support Level
- CNMD $71.28
- TNDM $31.89
- Resistance Level
- CNMD $72.49
- TNDM $34.48
- Average True Range (ATR)
- CNMD 2.78
- TNDM 1.80
- MACD
- CNMD -0.72
- TNDM 0.40
- Stochastic Oscillator
- CNMD 6.11
- TNDM 94.21
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
About TNDM Tandem Diabetes Care Inc.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.